PortfoliosLab logoPortfoliosLab logo
DRREDDY.NS vs. ^BSESN
Performance
Return for Risk
Drawdowns
Volatility

Performance

DRREDDY.NS vs. ^BSESN - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Dr. Reddy's Laboratories Limited (DRREDDY.NS) and S&P BSE SENSEX (^BSESN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DRREDDY.NS vs. ^BSESN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DRREDDY.NS
Dr. Reddy's Laboratories Limited
-4.86%-7.75%20.19%38.13%-13.08%-5.48%82.87%10.49%9.34%-20.41%
^BSESN
S&P BSE SENSEX
-14.18%9.06%8.17%18.74%4.44%21.99%15.75%14.38%5.91%27.91%

Returns By Period

In the year-to-date period, DRREDDY.NS achieves a -4.86% return, which is significantly higher than ^BSESN's -14.18% return. Over the past 10 years, DRREDDY.NS has underperformed ^BSESN with an annualized return of 8.06%, while ^BSESN has yielded a comparatively higher 11.21% annualized return.


DRREDDY.NS

1D
-3.61%
1M
-6.55%
YTD
-4.86%
6M
-2.82%
1Y
5.85%
3Y*
9.97%
5Y*
6.36%
10Y*
8.06%

^BSESN

1D
1.65%
1M
-8.85%
YTD
-14.18%
6M
-9.69%
1Y
-3.80%
3Y*
7.43%
5Y*
7.89%
10Y*
11.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DRREDDY.NS vs. ^BSESN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DRREDDY.NS
DRREDDY.NS Risk / Return Rank: 4646
Overall Rank
DRREDDY.NS Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
DRREDDY.NS Sortino Ratio Rank: 4242
Sortino Ratio Rank
DRREDDY.NS Omega Ratio Rank: 4141
Omega Ratio Rank
DRREDDY.NS Calmar Ratio Rank: 4848
Calmar Ratio Rank
DRREDDY.NS Martin Ratio Rank: 4949
Martin Ratio Rank

^BSESN
^BSESN Risk / Return Rank: 55
Overall Rank
^BSESN Sharpe Ratio Rank: 66
Sharpe Ratio Rank
^BSESN Sortino Ratio Rank: 66
Sortino Ratio Rank
^BSESN Omega Ratio Rank: 66
Omega Ratio Rank
^BSESN Calmar Ratio Rank: 66
Calmar Ratio Rank
^BSESN Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRREDDY.NS vs. ^BSESN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (DRREDDY.NS) and S&P BSE SENSEX (^BSESN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DRREDDY.NS^BSESNDifference

Sharpe ratio

Return per unit of total volatility

0.27

-0.29

+0.56

Sortino ratio

Return per unit of downside risk

0.54

-0.31

+0.85

Omega ratio

Gain probability vs. loss probability

1.07

0.96

+0.11

Calmar ratio

Return relative to maximum drawdown

0.33

-0.28

+0.61

Martin ratio

Return relative to average drawdown

0.72

-1.13

+1.85

DRREDDY.NS vs. ^BSESN - Sharpe Ratio Comparison

The current DRREDDY.NS Sharpe Ratio is 0.27, which is higher than the ^BSESN Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of DRREDDY.NS and ^BSESN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DRREDDY.NS^BSESNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.27

-0.29

+0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.30

0.58

-0.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.32

0.70

-0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.53

0.47

+0.07

Correlation

The correlation between DRREDDY.NS and ^BSESN is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Drawdowns

DRREDDY.NS vs. ^BSESN - Drawdown Comparison

The maximum DRREDDY.NS drawdown since its inception was -64.85%, which is greater than ^BSESN's maximum drawdown of -60.91%. Use the drawdown chart below to compare losses from any high point for DRREDDY.NS and ^BSESN.


Loading graphics...

Drawdown Indicators


DRREDDY.NS^BSESNDifference

Max Drawdown

Largest peak-to-trough decline

-64.85%

-60.91%

-3.94%

Max Drawdown (1Y)

Largest decline over 1 year

-14.56%

-16.11%

+1.55%

Max Drawdown (5Y)

Largest decline over 5 years

-32.67%

-16.85%

-15.82%

Max Drawdown (10Y)

Largest decline over 10 years

-48.03%

-38.07%

-9.96%

Current Drawdown

Current decline from peak

-13.77%

-14.80%

+1.03%

Average Drawdown

Average peak-to-trough decline

-19.86%

-13.76%

-6.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.65%

4.04%

+2.61%

Volatility

DRREDDY.NS vs. ^BSESN - Volatility Comparison

Dr. Reddy's Laboratories Limited (DRREDDY.NS) has a higher volatility of 8.58% compared to S&P BSE SENSEX (^BSESN) at 7.42%. This indicates that DRREDDY.NS's price experiences larger fluctuations and is considered to be riskier than ^BSESN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DRREDDY.NS^BSESNDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.58%

7.42%

+1.16%

Volatility (6M)

Calculated over the trailing 6-month period

15.47%

9.89%

+5.58%

Volatility (1Y)

Calculated over the trailing 1-year period

21.58%

13.39%

+8.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.68%

13.79%

+7.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.66%

16.29%

+9.37%